SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-17-003725
Filing Date
2017-03-08
Accepted
2017-03-08 17:09:46
Documents
5
Effectiveness Date
2017-03-08

Document Format Files

Seq Description Document Type Size
1 S-8 - EQUITY PLAN xene-s8.htm S-8 187780
2 EX-5.1 xene-ex51_42.htm EX-5.1 10065
3 EX-23.1 xene-ex231_40.htm EX-23.1 19687
4 GRAPHIC g2017030820321463628113.jpg GRAPHIC 15580
5 GRAPHIC g2017030820321690628250.jpg GRAPHIC 2469
  Complete submission text file 0001564590-17-003725.txt   243699
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216543 | Film No.: 17675878
SIC: 2834 Pharmaceutical Preparations